Outcomes-Based Contracts Aren’t So Easy, Harvard Pilgrim Cautions

Value-based, risk-sharing reimbursement contracts were a hot topic at ISPOR, but Harvard Pilgrim Health Care Chief Medical Officer Michael Sherman cautioned that finding the right drug and the right pharma partner to work with are challenging.

More from Pricing Debate

More from Market Access